TGF-β signaling is involved in pancreatic ductal adenocarcinoma (PDAC) tumorigenesis, representing one of the four major pathways genetically altered in 100% of PDAC cases. The gene discussed is TGFB1; the disease is pancreatic ductal adenocarcinoma.